Mark A. Smith
Impact in
- Physiology top 0.01%
- Alzheimer's disease research and treatments
- Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Physiology 477
- Alzheimer's disease research and treatments 470
- Neurology 32
- Parkinson's Disease Mechanisms and Treatments 30
- Co-authors
- George Perry (251 shared papers)Xiongwei Zhu (251 shared papers)Lawrence M. Sayre (40 shared papers)Akihiko Nunomura (109 shared papers)Rudolph J. Castellani (110 shared papers)Hyoung‐gon Lee (134 shared papers)Peggy L.R. Harris (48 shared papers)Arun K. Raina (45 shared papers)
- Journals
- Journal of Alzheimer s Disease (37 papers)Journal of Neurochemistry (33 papers)Free Radical Biology and Medicine (20 papers)Journal of Neuropathology & Experimental Neurology (15 papers)Brain Research (15 papers)
- Partner nations
- United StatesJapanPortugal
In The Last Decade
Mark A. Smith
633 papers receiving 62.5k citations
Mark A. Smith's Hit Papers
Peers
Comparison fields: 5 of 178
- Physiology 31.4k
- Neurology 4.4k
- Aging 812
- Biochemistry 3.1k
- Clinical Biochemistry 1.9k
Countries citing papers authored by Mark A. Smith
This map shows the geographic impact of Mark A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Smith more than expected).
Fields of papers citing papers by Mark A. Smith
This network shows the impact of papers produced by Mark A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Smith. The network helps show where Mark A. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 635 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes Hit paper breakdown → | 2008 | 1996 |
| 2 | Oxidative Damage Is the Earliest Event in Alzheimer Disease Hit paper breakdown → | 2001 | 1644 |
| 3 | Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Hit paper breakdown → | 1997 | 1208 |
| 4 | Mitochondrial Abnormalities in Alzheimer's Disease Hit paper breakdown → | 2001 | 1194 |
| 5 | Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease Hit paper breakdown → | 1997 | 1126 |
| 6 | Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease Hit paper breakdown → | 2009 | 1076 |
| 7 | 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease Hit paper breakdown → | 1997 | 905 |
| 8 | Oxidative damage in Alzheimer's Hit paper breakdown → | 1996 | 830 |
| 9 | Oxidative stress in Alzheimer’s disease Hit paper breakdown → | 2000 | 784 |
| 10 | Oxidative Stress and Neurotoxicity Hit paper breakdown → | 2007 | 745 |
| 11 | 2001 | 727 | |
| 12 | Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Hit paper breakdown → | 1994 | 657 |
| 13 | 1999 | 645 | |
| 14 | Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology Hit paper breakdown → | 2009 | 626 |
| 15 | Parkinson's Disease Is Associated with Oxidative Damage to Cytoplasmic DNA and RNA in Substantia Nigra Neurons Hit paper breakdown → | 1999 | 545 |
| 16 | 2001 | 534 | |
| 17 | 2006 | 521 | |
| 18 | 1994 | 515 | |
| 19 | 2003 | 505 | |
| 20 | 2000 | 497 |
About Mark A. Smith
Mark A. Smith is a scholar working on Physiology, Neurology, Neurology, Molecular Biology and Clinical Biochemistry, having authored 635 papers that have together received 64.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (470 papers), Mitochondrial Function and Pathology (37 papers), Parkinson's Disease Mechanisms and Treatments (30 papers), Redox biology and oxidative stress (29 papers), Dementia and Cognitive Impairment Research (26 papers), Advanced Glycation End Products research (18 papers), Antioxidant Activity and Oxidative Stress (18 papers) and Trace Elements in Health (15 papers). The work is most often cited by research in Physiology (31.4k citations), Neurology (4.4k citations), Aging (812 citations), Biochemistry (3.1k citations) and Clinical Biochemistry (1.9k citations). Mark A. Smith has collaborated with scholars based in United States, Japan and Portugal. Frequent co-authors include George Perry, Xiongwei Zhu, Lawrence M. Sayre, Akihiko Nunomura, Rudolph J. Castellani, Hyoung‐gon Lee, Peggy L.R. Harris, Arun K. Raina, Paula Isabel Moreira and Sandra L. Siedlak. Their work appears in journals such as Journal of Alzheimer s Disease, Journal of Neurochemistry, Free Radical Biology and Medicine, Journal of Neuropathology & Experimental Neurology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.